An explanation of the low shorts could be because the SPL share...

An explanation of the low shorts could be because the SPL share price was pole axed last year after its partner AstraZeneca terminated a 3rd drug development program with Starpharma. That’s when even patient institutional investors lost faith and capitulated.

Since then it’s been nothing but a rolling series of poor or fluff ASX announcements grinding the share price to historic lows and finally seeing Starpharma being unceremoniously dumped from the All Ordinaries Index this year and hence losing almost all remaining credibility as an investment worthy company.

Now as a penny stock below even the minimum benchmark of the All Ordinaries, I would think it would be very hard to find a broker willing to facilitate short trading of SPL.

I would caution against assuming this is the bottom. It may be, but I suspect solid tax loss selling will begin in May/June without a major catalyst. Things could get certainly get decidedly uglier.

DYOR

P.S. Fortune favours the brave, but curiosity also killed the cat.